Tower Research Capital (TRC)’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,308
| Closed | -$23.6K | – | 5688 |
|
|
2025
Q1 | $23.6K | Buy |
1,308
+43
| +3% | +$764 | ﹤0.01% | 2814 |
|
|
2024
Q4 | $22.1K | Sell |
1,265
-9,149
| -88% | -$124K | ﹤0.01% | 3110 |
|
|
2024
Q3 | $120K | Sell |
10,414
-1
| -0% | -$11 | ﹤0.01% | 2091 |
|
|
2024
Q2 | $118K | Buy |
10,415
+9,838
| +1,705% | +$131K | ﹤0.01% | 2459 |
|
|
2024
Q1 | $8.26K | Sell |
577
-11,849
| -95% | -$168K | ﹤0.01% | 4054 |
|
|
2023
Q4 | $170K | Buy |
12,426
+11,145
| +870% | +$117K | ﹤0.01% | 2232 |
|
|
2023
Q3 | $10.4K | Buy |
1,281
+305
| +31% | +$2.49K | ﹤0.01% | 4112 |
|
|
2023
Q2 | $7.39K | Sell |
976
-3,594
| -79% | -$27.4K | ﹤0.01% | 4580 |
|
|
2023
Q1 | $37K | Buy |
4,570
+1,695
| +59% | +$17.4K | ﹤0.01% | 2794 |
|
|
2022
Q4 | $33K | Sell |
2,875
-1,787
| -38% | -$19.5K | ﹤0.01% | 2675 |
|
|
2022
Q3 | $41K | Sell |
4,662
-3,082
| -40% | -$32K | ﹤0.01% | 3339 |
|
|
2022
Q2 | $77K | Buy |
7,744
+7,111
| +1,123% | +$71.6K | ﹤0.01% | 2505 |
|
|
2022
Q1 | $6K | Sell |
633
-550
| -46% | -$5.85K | ﹤0.01% | 4950 |
|
|
2021
Q4 | $15K | Sell |
1,183
-1,444
| -55% | -$18.8K | ﹤0.01% | 4019 |
|
|
2021
Q3 | $32K | Buy |
2,627
+985
| +60% | +$13.4K | ﹤0.01% | 3331 |
|
|
2021
Q2 | $25K | Sell |
1,642
-5,687
| -78% | -$85.3K | ﹤0.01% | 3697 |
|
|
2021
Q1 | $101K | Buy |
7,329
+4,913
| +203% | +$76.2K | ﹤0.01% | 2576 |
|
|
2020
Q4 | $44K | Sell |
2,416
-5,475
| -69% | -$84.5K | ﹤0.01% | 3237 |
|
|
2020
Q3 | $100K | Buy |
+7,891
| New | +$98.9K | ﹤0.01% | 3148 |
|
Tower Research Capital (TRC)'s PTVE Position: Q2 2025 in Review
Tower Research Capital (TRC) sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 1,308 shares — an estimated $23.6K sold.
Tower Research Capital (TRC) first reported a position in PTVE in Q3 2020 and held it in 19 quarters. The position peaked at $170K in Q4 2023. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Tower Research Capital (TRC) reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,308 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $23.6K.
- Tower Research Capital (TRC) first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 19 quarters.
- Tower Research Capital (TRC)'s Pactiv Evergreen Inc. Common stock position peaked at $170K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.